Trial Details

RECRUITING
Basic Information
Clinical ID c1796
Identifier NCT06715540
Trial Title Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Healthy
Interventions DRUG: BCD-261, dose 1|DRUG: BCD-261, dose 2|DRUG: BCD-261, dose 3|DRUG: BCD-261, dose 4|DRUG: BCD-261, dose 5|DRUG: BCD-261, dose 6|DRUG: BCD-261, pre-specified therapeautic dose X|DRUG: BCD-261, pre-specified therapeautic dose X|DRUG: BCD-261, pre-specified therapeautic dose Y
Participant Information
Sponsor Biocad
City St. Petersburg
Country/Region Russian Federation
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2024-03-29
Primary Completion Date 2025-02-25
Completion Date 2025-12-25